The charity Humankind has launched a new minimum standards document for their organisations harm reduction services. The new standards are intended to improve equitable access to needle and syringe provision and reduce the stigma and discrimination faced by people who use substances.
The new guidelines have been welcomed by others working in the sector. “I am delighted to see drive to improve the care we offer to some of our most vulnerable members of society”, said Professor Graham Foster, Professor of Hepatology at Queen Mary University of London and National Clinical Chair for the Hepatitis C Delivery Networks.
“Preventing avoidable harms by high quality needle exchange is one of the most effective ways of improving health and reducing costs and this initiative will help in our goals to build back better after the pandemic”, Foster added.
